Trademark: 79295569
Word
ONE-STOP-SITE
Status
Registered
Status Code
700
Status Date
Tuesday, August 24, 2021
Serial Number
79295569
Registration Number
6458312
Registration Date
Tuesday, August 24, 2021
Mark Type
4000
Filing Date
Tuesday, June 2, 2020
Published for Opposition
Tuesday, June 8, 2021

Trademark Owner History
Hovione Scientia Limited - Original Registrant

Classifications
5 Compositions for medical and veterinarian use, namely, chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals; diagnostic preparations for medical purposes; chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals; pharmaceutical active ingredients, namely, sold as a component ingredient of pharmaceutical preparations, and pharmaceutical preparations and compounds, all of the foregoing for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders; all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals
1 Active chemical ingredients for use in the manufacture of pharmaceuticals for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals
42 Development of pharmaceutical products and drug products; research on pharmaceutical products and drug products; research and development of new products in the pharmaceutical industry; Consulting services in the field of design and development of engineering processes for the pharmaceutical industry; research and development services in the pharmaceutical field; research and development services in the field of pharmaceuticals, chemical preparations, vaccines, medicines, antibodies, new products in the medical field

Trademark Events
May 26, 2023
New Representative At Ib Received
Feb 28, 2022
Final Decision Transaction Processed By Ib
Feb 4, 2022
Final Disposition Notice Sent To Ib
Feb 3, 2022
Final Disposition Processed
Nov 24, 2021
Final Disposition Notice Created, To Be Sent To Ib
Aug 24, 2021
Registered-Principal Register
Jun 8, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 8, 2021
Published For Opposition
May 19, 2021
Notification Of Notice Of Publication E-Mailed
May 14, 2021
New Representative At Ib Received
May 5, 2021
Approved For Pub - Principal Register
May 4, 2021
Teas/Email Correspondence Entered
May 4, 2021
Correspondence Received In Law Office
May 4, 2021
Teas Response To Office Action Received
Nov 29, 2020
Refusal Processed By Ib
Nov 6, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Nov 5, 2020
Refusal Processed By Mpu
Oct 20, 2020
Application Filing Receipt Mailed
Oct 16, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Oct 15, 2020
Non-Final Action Written
Oct 14, 2020
Assigned To Examiner
Oct 14, 2020
New Application Office Supplied Data Entered
Oct 8, 2020
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24